SCHEMBL3342272

SCHEMBL3342272

COC(=O)c1c(Cl)ccnc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 4/20 0.41
TSHR P16473 3/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
POLB P06746 2/20 0.39
TYK2 P29597 2/20 0.39
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
KDM6B O15054 1/20 0.38
KDM5C P41229 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
KDM3A Q9Y4C1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30227922 0.82 ATR (0.46) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL15454465 0.82 ALDH1A1 (0.43) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL56989 0.82 ATR (0.46) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL28964614 0.82 ATR (0.41) ALDH1A1POLBATRLMNAKMT2A
SCHEMBL844466 0.82 CA12 (0.45) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL27373972 0.81 CA12 (0.46) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL14352047 0.81 CA12 (0.41) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL31214389 0.81 CA12 (0.41) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL27532136 0.80 TYK2 (0.37) ALDH1A1KDM4ETYK2JAK2JAK1
SCHEMBL4231441 0.79 ALDH1A1 (0.41) ALDH1A1KDM4ETSHRHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090480-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-05-01 WO disclosed
CN-110300754-A Pyrrolo [1,2-b ] pyridazine derivatives 吉利德科学公司 2019-10-01 CN disclosed
WO-2010038081-A2 HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2010-04-08 WO disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed
EP-1861393-A2 PYRROLE DERIVATIVES AS DNA GYRASE AND TOPOISOMERASE INHIBITORS AstraZeneca AB (SE) 2007-12-05 EP disclosed
WO-2006092599-A2 PYRROLE DERIVATIVES AS DNA GYRASE AND TOPOISOMERASE INHIBITORS ASTRAZENECA AB (SE) 2006-09-08 WO disclosed